title: Effectiveness of treatment with high-frequency chest wall oscillation in patients with bronchiectasis.
abstract: BACKGROUND
  High-frequency airway clearance (HFCWC) assist devices generate either positive or negative trans-respiratory pressure excursions to produce high-frequency, small-volume oscillations in the airways.HFCWC can lead to changes in volume of 15-57 ml and in flow up to 1.6 L/s, which generate minimal coughing to mobilize secretions. The typical treatment lasts 20-30 minutes, and consists of short periods of compression at different frequencies, separated by coughing.The aim of this study was to find the more efficacious treatment in patients with bronchiectasis: traditional techniques of chest physiotherapy (CPT) versus high frequency oscillation of the chest wall in patients with bronchiectasis.
  
  
  METHODS
  37 patients were enrolled. Seven of them were excluded. Computer randomization divided the patients into three groups: - 10 patients treated with HFCWO by using the Vest® Airway Clearance System; - 10 patients treated with traditional techniques of air way clearance (PEP bottle, PEP mask, ELTGOL, vibratory positive expiratory pressure); - 10 patients received medical therapy only (control group). To be eligible for enrollment, participants had to be between 18 and 85 years old and have a diagnosis of bronchiectasis, confirmed on high resolution computed tomography.
  
  
  METHODS
  lack of informed consent, signs of exacerbation, cystic fibrosis. Before the treatment, each patient had blood tests, sputum volume and cell count, pulmonary function tests and on the quality of life inventories (MMRC, CAT, BCSS). The results were processed through the covariance analysis, performed with the R-Project statistical program. It has been considered a positive result p <005.
  
  
  RESULTS
  Both treatments (traditional CPT and HFCWO) showed a significant improvement in some biochemical and functional respiratory tests as well as in the quality of life compared to the control group. The use of HFCWO compared to CPT also produced a significant improvement in blood inflammation parameter C-RP (p ≤0.019), parameters of lung functionality associated with bronchial obstruction (FVC, FEV1) (p ≤0.006 and p ≤0.001), and in the dyspnea. Improvement in quality of life scales was noted. (BCSS, CAT) (both p ≤0.001). No significant changes of total cell counts in sputum samples were observed in the two groups. In the HFCWO group a significant reduction of neutrophils percentage (p≤0.002) and a significant increase of macrophages percentage (p ≤0.012).
  
  
  CONCLUSIONS
  The HFCWO technique provides an improvement both in pulmonary function and quality of life related parameters in patients with chronic hypersecretive disease. Since those patients need daily airway clearance, this treatment should be included among the principal options in chest physiotherapy. The study was registered as ChiCTR-TRC-12002134 at http://www.chictr.org.
authors.affiliation: Respiratory Diseases Unit, General Hospital of Sestri Levante, Genoa, Italy. antonello.nicolini@fastwebnet.it
authors.forename: Antonello
authors.initials: A
authors.lastname: Nicolini
authors.forename: Federica
authors.initials: F
authors.lastname: Cardini
authors.forename: Norma
authors.initials: N
authors.lastname: Landucci
authors.forename: Sergio
authors.initials: S
authors.lastname: Lanata
authors.forename: Maura
authors.initials: M
authors.lastname: Ferrari-Bravo
authors.forename: Cornelius
authors.initials: C
authors.lastname: Barlascini
mesh_terms: D000368:Aged; D001987:Bronchiectasis / Q000503:physiopathology* / Q000628:therapy*; D035641:Chest Wall Oscillation / Q000379:methods*; D003371:Cough / Q000503:physiopathology*; D004417:Dyspnea / Q000503:physiopathology / Q000628:therapy; D005260:Female; D006801:Humans; D008168:Lung / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011659:Pulmonary Gas Exchange / Q000502:physiology; D013183:Sputum / Q000502:physiology; D016896:Treatment Outcome
references.citation: Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1172-4
references.pmid: 10988149
references.citation: BMC Pulm Med. 2007 Dec 10;7:17
references.pmid: 18070340
references.citation: Thorax. 2010 Mar;65(3):196-200
references.pmid: 19703826
references.citation: Am J Respir Crit Care Med. 1994 Oct;150(4):1154-7
references.pmid: 7921452
references.citation: Eur Respir J. 2005 Aug;26(2):319-38
references.pmid: 16055882
references.citation: Respir Res. 2011 Sep 10;12:120
references.pmid: 21906390
references.citation: Chest. 2007 Oct;132(4):1227-32
references.pmid: 17890465
references.citation: Arch Bronconeumol. 2011 Dec;47(12):599-609
references.pmid: 21798654
references.citation: Thorax. 2011 May;66(5):425-9
references.pmid: 21398686
references.citation: Thorax. 2009 May;64 Suppl 1:i1-51
references.pmid: 19406863
references.citation: Chron Respir Dis. 2004;1(3):127-30
references.pmid: 16281653
references.citation: Respir Care. 2007 Aug;52(8):1000-5
references.pmid: 17650355
references.citation: Curr Opin Pediatr. 2006 Dec;18(6):604-13
references.pmid: 17099358
references.citation: Chron Respir Dis. 2007;4(1):23-30
references.pmid: 17416150
references.citation: Int J Chron Obstruct Pulmon Dis. 2011;6:693-9
references.pmid: 22259246
references.citation: Respir Care. 2003 Jan;48(1):24-8
references.pmid: 12556258
references.citation: Rev Bras Fisioter. 2012 Apr;16(2):108-13
references.pmid: 22481696
references.citation: J Clin Med Res. 2011 Dec;3(6):279-84
references.pmid: 22393338
references.citation: Eur Respir J. 1999 Dec;14(6):1418-24
references.pmid: 10624775
references.citation: Ann Thorac Med. 2011 Jul;6(3):131-6
references.pmid: 21760844
references.citation: Thorax. 1978 Oct;33(5):635-7
references.pmid: 725832
references.citation: J Appl Physiol Respir Environ Exerc Physiol. 1984 Mar;56(3):700-7
references.pmid: 6706776
references.citation: J Clin Pharm Ther. 2006 Feb;31(1):49-55
references.pmid: 16476120
references.citation: N Engl J Med. 2002 May 2;346(18):1383-93
references.pmid: 11986413
references.citation: Ther Adv Respir Dis. 2010 Apr;4(2):93-9
references.pmid: 20388725
references.citation: J Trauma Manag Outcomes. 2008 Oct 06;2(1):8
references.pmid: 18837992
references.citation: COPD. 2005 Mar;2(1):27-34
references.pmid: 17136958
references.citation: Chest. 2008 Feb;133(2):468-73
references.pmid: 18071019
references.citation: Chest. 2006 Jan;129(1 Suppl):250S-259S
references.pmid: 16428718
references.citation: Respir Care. 2011 Jul;56(7):984-8
references.pmid: 21352670
references.citation: J Bras Pneumol. 2008 Nov;34(11):913-21
references.pmid: 19099097
references.citation: Tuberc Respir Dis (Seoul). 2012 Jun;72(6):467-74
references.pmid: 23101012
references.citation: Phys Ther. 2005 Dec;85(12):1278-89
references.pmid: 16305267
references.citation: Pediatr Pulmonol. 1991;11(3):265-71
references.pmid: 1758749
references.citation: Thorax. 2010 Mar;65(3):189-90
references.pmid: 20335283
references.citation: Respirology. 2005 Jan;10(1):46-56
references.pmid: 15691238
references.citation: Chest. 2003 Dec;124(6):2182-91
references.pmid: 14665499
references.citation: Chest. 2008 Oct;134(4):815-823
references.pmid: 18842914
references.citation: Physiother Theory Pract. 2010 Apr 22;26(3):143-9
references.pmid: 20331370
references.citation: Respir Care. 2010 Jun;55(6):695-701
references.pmid: 20507651
references.citation: Respir Care. 2013 Feb;58(2):298-304
references.pmid: 22906833
references.citation: Pediatr Pulmonol. 2001 Nov;32(5):372-7
references.pmid: 11596162
references.citation: Respir Med. 2008 Aug;102(8):1140-4
references.pmid: 18585027
references.citation: Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):308-17
references.pmid: 8756799
references.citation: Curr Opin Infect Dis. 2008 Apr;21(2):163-7
references.pmid: 18317040